pharmaphorum October 19, 2021
A new poll of clinical trial sponsors has found that around nine out of 10 of them are running decentralised trials with the help of digital technologies, a big increase on pre-COVID-19 levels.
The survey by Veeva Systems found a big increase in the adoption of technologies that enabled remote trials during COVID-19, with increased use of tools such as remote monitoring, electronic data collection and consent forms, and web portals for studies.
Prior to the pandemic 28% of recipients – mainly biopharma companies and contract research organisations (CROs) – were running decentralised trials, but that has now risen to 87%, according to the report.
Despite the shift, trial sponsors are still dealing with a fragmented landscape that is raising...
Today's Sponsors
Today's Sponsor